This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Lion Corporation. Active years: 2016-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2019
Title: Innovations by Kei Kurita
Introduction
Kei Kurita is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of biomedical research, particularly in the development of marker peptides for health diagnostics. With a total of 3 patents, his work focuses on identifying risks associated with metabolic syndrome and hyperglycemia.
Latest Patents
Kurita's latest patents include a marker peptide for determining the risk of developing metabolic syndrome. This invention aims to provide a reliable marker substance that can accurately assess the risk of metabolic syndrome in vivo. The patent outlines a method for determining this risk through the measurement of the marker peptide in biological samples. Additionally, he has developed a marker peptide for determining the risk of hyperglycemia, which also includes methods and kits for accurate assessment.
Career Highlights
Kei Kurita is currently associated with Lion Corporation, where he continues to innovate in the field of health diagnostics. His work has the potential to significantly impact the way metabolic disorders are diagnosed and managed.
Collaborations
Some of his notable coworkers include Chiyoko Uchiyama and Riichi Maki, who contribute to the collaborative efforts in research and development at Lion Corporation.
Conclusion
Kei Kurita's innovative work in developing marker peptides for health diagnostics showcases his commitment to advancing medical science. His contributions are paving the way for more accurate and effective methods of assessing health risks.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile